NYSEARCA:SRXH - US08771Y4026 - Common Stock
The current stock price of SRXH is 0.39 USD. In the past month the price decreased by -11.77%. In the past year, price decreased by -87.45%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MDLZ | MONDELEZ INTERNATIONAL INC-A | 19.91 | 80.11B | ||
HSY | HERSHEY CO/THE | 21.79 | 36.79B | ||
KHC | KRAFT HEINZ CO/THE | 9.5 | 32.61B | ||
K | KELLANOVA | 21.77 | 27.80B | ||
GIS | GENERAL MILLS INC | 11.69 | 26.31B | ||
TSN | TYSON FOODS INC-CL A | 14.74 | 20.39B | ||
MKC | MCCORMICK & CO-NON VTG SHRS | 24.1 | 18.88B | ||
MKC.V | MCCORMICK & CO INC VTG COM | 23.97 | 18.79B | ||
HRL | HORMEL FOODS CORP | 19.32 | 15.83B | ||
JBS | JBS NV-A | 8.17 | 12.77B | ||
SJM | JM SMUCKER CO/THE | 10.96 | 11.83B | ||
PPC | PILGRIM'S PRIDE CORP | 7.41 | 10.55B |
Better Choice Co., Inc. is an animal health and wellness company. The company is headquartered in Oldsmar, Florida and currently employs 20 full-time employees. The company went IPO on 2010-06-16. The firm offers a portfolio of pet health and wellness products for dogs and cats sold under its Halo brand in multiple forms, including foods, treats, toppers, dental products, chews and supplements. Its products consist of kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements. The company offers products in different channels: Digital, which includes the sale of products to online retailers such as Amazon and Chewy; Brick & Mortar, which includes the sale of products to pet specialty retailers, independent pet stores, and regional distributors; and International, which includes the sale of products to foreign distribution partners and to select international retailers. The firm also operates a specialty pharmacy business through its wholly-owned subsidiary SRx Health Solutions (Canada) Inc.
SRX HEALTH SOLUTIONS INC
4025 Tampa Rd Ste 1117
Oldsmar FLORIDA US
CEO: Scott Lerner
Employees: 20
Phone: 16468464280
The current stock price of SRXH is 0.39 USD. The price decreased by -3.49% in the last trading session.
The exchange symbol of SRX HEALTH SOLUTIONS INC is SRXH and it is listed on the NYSE Arca exchange.
SRXH stock is listed on the NYSE Arca exchange.
7 analysts have analysed SRXH and the average price target is 10.2 USD. This implies a price increase of 2515.38% is expected in the next year compared to the current price of 0.39. Check the SRX HEALTH SOLUTIONS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SRX HEALTH SOLUTIONS INC (SRXH) has a market capitalization of 6.01M USD. This makes SRXH a Nano Cap stock.
SRX HEALTH SOLUTIONS INC (SRXH) currently has 20 employees.
SRX HEALTH SOLUTIONS INC (SRXH) has a support level at 0.36 and a resistance level at 0.42. Check the full technical report for a detailed analysis of SRXH support and resistance levels.
The Revenue of SRX HEALTH SOLUTIONS INC (SRXH) is expected to grow by 25% in the next year. Check the estimates tab for more information on the SRXH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SRXH does not pay a dividend.
SRX HEALTH SOLUTIONS INC (SRXH) will report earnings on 2025-11-10.
SRX HEALTH SOLUTIONS INC (SRXH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.43).
The outstanding short interest for SRX HEALTH SOLUTIONS INC (SRXH) is 0.69% of its float. Check the ownership tab for more information on the SRXH short interest.
ChartMill assigns a fundamental rating of 3 / 10 to SRXH. While SRXH seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months SRXH reported a non-GAAP Earnings per Share(EPS) of -2.43. The EPS increased by 107.92% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.96% | ||
ROA | 11.11% | ||
ROE | 21.33% | ||
Debt/Equity | 0 |
7 analysts have analysed SRXH and the average price target is 10.2 USD. This implies a price increase of 2515.38% is expected in the next year compared to the current price of 0.39.
For the next year, analysts expect an EPS growth of 273.33% and a revenue growth 25% for SRXH